## AMP: Ameriprise Financial, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 1.2% below STRENGTH zone (4.0-10.0%); PEG 1.77 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($477.21)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. The Truth About Ameriprise Financial: Why Everyone Is Suddenly Paying Attention**
- Source: AD HOC NEWS | 20260102T200810 | Somewhat-Bullish | Relevance: 100%
- This article delves into Ameriprise Financial (AMP), examining whether the "old-school" financial giant is a valuable long-term investment or service provider in today's financial landscape. It analyzes AMP's business model, stock performance, and client experience, comparing it to competitors like Charles Schwab. The article concludes with a "cop or drop" verdict for both potential investors and clients, emphasizing Ameriprise's focus on stability and long-term planning over viral trends.

**2. Who Owns Ameriprise Financial? Top Shareholders and Recent Insider Trades**
- Source: TIKR.com | 20260101T220837 | Neutral | Relevance: 100%
- This article examines the major shareholders and recent insider trading activities of Ameriprise Financial, Inc. (NYSE: AMP). It highlights that the company's ownership is primarily stable institutional investors like Vanguard and BlackRock, with some hedge funds increasing their stakes. Insider trading activity, however, appears limited and focused on personal exposure rather than strong directional views on the stock.

**3. The Truth About Ameriprise Financial: Why Everyone Is Suddenly Paying Attention**
- Source: AD HOC NEWS | 20260102T201107 | Somewhat-Bullish | Relevance: 95%
- Ameriprise Financial is gaining attention as a stable, long-term investment and financial planning option, contrasting with volatile meme stocks and fintech apps. The article explores AMP's stock performance, client experience, and compares it to competitors like Charles Schwab, concluding it's a "quiet cop" for investors and a "cop" for clients seeking structured, human-led financial guidance. It emphasizes Ameriprise's focus on steady growth and recurring revenue from services like wealth management, retirement planning, and insurance.

**4. Balance Wealth LLC Has $1.57 Million Stake in Columbia Research Enhanced Core ETF $RECS**
- Source: Defense World | 20260101T090855 | Somewhat-Bullish | Relevance: 67%
- Balance Wealth LLC reduced its stake in Columbia Research Enhanced Core ETF (NYSEARCA:RECS) by 29.0% in the third quarter, holding $1.57 million worth of shares. Other institutional investors like Jane Street Group LLC, Ameriprise Financial Inc., Raymond James Financial Inc., Commonwealth Equity Services LLC, and Gradient Investments LLC also adjusted their positions in RECS. The article also provides key financial metrics for RECS, including its market capitalization, price-to-earnings ratio, and moving averages.

**5. Marten Transport (NASDAQ:MRTN) Stock Passes Above 200 Day Moving Average - Time to Sell?**
- Source: MarketBeat | 20260101T080927 | Neutral | Relevance: 65%
- Marten Transport (NASDAQ:MRTN) briefly traded above its 200-day moving average but closed lower, raising questions about selling opportunities. The company missed quarterly earnings and revenue estimates, and analysts hold a consensus "Hold" rating with an average price target of $19.00. Marten's 100% dividend payout ratio for its $0.06 quarterly dividend (2.1% yield) also raises concerns about its sustainability.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Morgan Stanley | $485 | $484 | +0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Morgan Stanley | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.05M) |
| Sells | 1 ($0.68M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 13.3% (-0.5%)
- JPMORGAN CHASE & CO: 10.3% (+53.2%)
- Blackrock Inc.: 9.7% (-5.2%)
- State Street Corpora: 4.8% (+0.4%)
- Geode Capital Manage: 3.1% (+0.8%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-1.6% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.77 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 60%, margin 20%). Balance sheet: strong liquidity (308.1x), $2.2B free cash flow. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $46.5B |
| Beta | 1.26 |
| 52W Range | $396.14 - $582.05 |
| Short Interest | 3.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.77 |
| Forward P/E | 11.9 |
| Current P/E | 12.8 |
| YoY Growth | 7.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 2.8% to 1.2% (-1.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.8pp (needs >4.0% for momentum thesis). MRS_5 at 0.3% confirms short-term momentum alignment. Below SMA200 (1.00x), long-term trend not supportive. MACD histogram bearish (-0.57), momentum weakening. RSI neutral at 59. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.22% (CS: 58) | Neutral |
| RSI_14 | 58.8 | Neutral |
| MACD Histogram | -0.57 | Bearish |
| vs SMA20 | 1.007x | Above |
| vs SMA50 | 1.046x | Above |
| vs SMA200 | 1.000x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $493.77
- **Stop Loss:** $477.21 (3.4% risk)
- **Target:** $510.33 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 86
- **Position Value:** $42,464.22
- **Portfolio %:** 42.46%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-01-28 (Est: $10.23)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $9.76 | $9.87 | +1.1% |
| 2025Q2 | $9.00 | $9.11 | +1.2% |
| 2025Q1 | $9.08 | $9.50 | +4.6% |
| 2024Q4 | $9.05 | $9.36 | +3.5% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*